The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer

Published:2024-07-24 Issue: Volume: Page:
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Wanis Kerollos Nashat,Goetz Lianna,So Alycia,Glencer Alexa C.,Sun Susie X.,Teshome Mediget,Resetkova Erika,Hwang Rosa F.,Hunt Kelly K.,Candelaria Rosalind P.,Huo Lei,Singh Puneet

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-15712-z.pdf

Reference30 articles.

1. Brackstone M, Baldassarre FG, Perera FE, et al. Management of the axilla in early-stage breast cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline. J Clin Oncol. 2021;39(27):3056–82. https://doi.org/10.1200/JCO.21.00934.

2. Rogers C, Cobb AN, Lloren JIC, et al. National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial. Breast Cancer Res Treat. 2024;203(2):317–28. https://doi.org/10.1007/s10549-023-07114-8.

3. Namdar ZM, Omidifar N, Arasteh P, et al. How accurate is frozen section pathology compared to permanent pathology in detecting involved margins and lymph nodes in breast cancer? World J Surg Oncol. 2021;19(1):261. https://doi.org/10.1186/s12957-021-02365-5.

4. Rana MK, Rana APS, Sharma U, Barwal TS, Jain A. Evolution of frozen section in carcinoma breast: systematic review. Int J Breast Cancer. 2022;2022:4958580. https://doi.org/10.1155/2022/4958580.

5. Czaja R, Wu R, Jorns JM. Breast sentinel lymph node frozen section practice: an enterprise audit as a guide for moving forward. Arch Pathol Lab Med. 2021;145(8):1018–24. https://doi.org/10.5858/arpa.2020-0411-OA.